Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.91 |
| ▸ | NPC1 | O15118 | 3/20 | 0.91 |
| ▸ | TP53 | P04637 | 2/20 | 0.88 |
| ▸ | HPGD | P15428 | 1/20 | 0.88 |
| ▸ | MEN1 | O00255 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.81 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | S1PR5 | Q9H228 | 10/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.64 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.64 |
| ▸ | LTA4H | P09960 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1046370 | 0.95 | TSHR (0.84) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL24514228 | 0.94 | RAB9A (1.00) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL3027800 | 0.94 | TSHR (0.88) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL3037458 | 0.94 | TSHR (0.82) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL3041996 | 0.92 | TSHR (0.91) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL22794496 | 0.90 | RAB9A (0.75) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL22790780 | 0.90 | RAB9A (0.75) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL24514290 | 0.90 | RAB9A (0.75) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL18182312 | 0.89 | RAB9A (0.91) | RAB9ANPC1TP53HPGDMEN1 | |
| SCHEMBL22790779 | 0.88 | RAB9A (0.72) | RAB9ANPC1TP53HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2269995-B1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DAINIPPON INK & CHEMICALS (JP) | 2012-12-12 | — | — | EP | disclosed |
| US-8017706-B2 | Process for production of polymers with iron complex catalyst | DIC CORPORATION (JP) | 2011-09-13 | — | — | US | disclosed |
| US-8017706-B2 | Process for production of polymers with iron complex catalyst | DIC CORPORATION (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20110105703-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DIC Corporatio (JP) | 2011-05-05 | — | — | US | disclosed |
| US-20110105703-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DIC Corporatio (JP) | 2011-05-05 | — | — | US | disclosed |
| EP-2269995-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DIC Corporation (JP) | 2011-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105703-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | TFRC, FECH, FTH1 | RAB9A 3391/4885NPC1 4475/4885TP53 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.